Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2021-09-21 00:00:00 ET · period of report 2021-09-17 · accession 0001519749-21-000011 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-09-21 | 2021-09-17 | MYGN | Hart Jayne B. | CHRO | M - OptEx | $26.49 | +77.0K | 92.6K | +494% | +$2.04M |
| DM | 2021-09-21 | 2021-09-17 | MYGN | Hart Jayne B. | CHRO | S - Sale+OE | $33.72 | -67.4K | 88.8K | -43% | -$2.27M |
| DM | 2021-09-21 | 2021-09-17 | MYGN | Hart Jayne B. | CHRO | M - OptEx | $0.00 | -77.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-17 | M | A | 73,225 | $26.49 | 153,287 | D | — | — | |
| 2 | Common | Common Stock | 2021-09-17 | S | D | 2,966 | $33.72 | 89,616 | D | — | — | |
| 3 | Common | Common Stock | 2021-09-17 | M | A | 3,775 | $26.49 | 92,582 | D | — | — | |
| 4 | Common | Common Stock | 2021-09-17 | S | D | 64,480 | $33.72 | 88,807 | D | — | — | |
| 5 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-09-17 | M | D | 73,225 | $0.00 | 0 | D | $26.49 · — to 2021-09-17 | 73,225 Common Stock | (F3) The shares subject to this option are fully vested and exercisable. |
| 6 | Derivative | Incentive Stock Option (right to buy) | 2021-09-17 | M | D | 3,775 | $0.00 | 0 | D | $26.49 · — to 2021-09-17 | 3,775 Common Stock | (F3) The shares subject to this option are fully vested and exercisable. |